In this episode, host Prof. Jan Gutermuth explores with Prof. Christoffer Gebhardt the evolving landscape of melanoma prognosis.
Together they discuss current strategies for predicting outcomes in melanoma patients, including clinical staging, histopathological features, and emerging molecular and genetic biomarkers. The conversation highlights how personalised medicine and novel diagnostic tools are shaping prognosis accuracy and guiding treatment decisions.
Ideal for dermatologists, oncologists, and researchers, this #EADVPodcast episode underscores the importance of integrating science and patient care to improve long-term survival in melanoma.
Your feedback is valued and appreciated to allow us to better serve our audience
